Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 3,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,753 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 14 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 2,009 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 13 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,009 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 12 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 847 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F7 · derivative.exercise_date: 846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026. F7 · derivative.expiration_date: 846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 11 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026. F6 · derivative.expiration_date: 2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 228 | $27.17 | $6,194.76 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 8 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,174 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 7 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,402 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 674 | $27.17 | $18,312.58 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 6 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,768 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 2,009 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 5 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,442 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 304 | $27.17 | $8,259.68 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 4 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,433 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,737 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 421 | $27.17 | $11,438.57 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,890 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,311 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 8 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F7 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026. F7 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 7 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026. F6 · derivative.expiration_date: 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 651 | $27.17 | $17,687.67 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 4 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,555 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,206 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 578 | $27.17 | $15,704.26 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,392 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,970 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantNon-Qualified Stock Options · Derivative | 36,150 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 10 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,150 Underlying: Common Stock · 36,150 shares Expires 2036-01-30 F5 · derivative.exercise_date: 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 00:51 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantRestricted Stock Units · Derivative | 36,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000004 · wk-form4_1770166259.xml · derivative · entry 9 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,152 Underlying: Common Stock · 36,152 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F4 · derivative.expiration_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:50 UTC |
Siegrist Jonathan PhilipEVP of R&D & CTO
|
GrantNon-Qualified Stock Options · Derivative | 36,150 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0002040321-26-000004 · wk-form4_1770166219.xml · derivative · entry 2 Siegrist Jonathan Philip · CIK 0002040321 · EVP of R&D & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,150 Underlying: Common Stock · 36,150 shares Expires 2036-01-30 F3 · derivative.exercise_date: 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:50 UTC |
Siegrist Jonathan PhilipEVP of R&D & CTO
|
GrantRestricted Stock Units · Derivative | 36,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002040321-26-000004 · wk-form4_1770166219.xml · derivative · entry 1 Siegrist Jonathan Philip · CIK 0002040321 · EVP of R&D & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,152 Underlying: Common Stock · 36,152 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation Common Stock. F2 · derivative.exercise_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F2 · derivative.expiration_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 00:48 UTC |
Blaser Brian J.President and CEO
|
GrantRestricted Stock Units · Derivative | 213,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001492289-26-000004 · wk-form4_1770166116.xml · derivative · entry 1 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,470 Underlying: Common Stock · 213,470 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 71,156 shares will vest on January 30, 2027; the remaining 142,314 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F2 · derivative.expiration_date: 71,156 shares will vest on January 30, 2027; the remaining 142,314 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 29,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000004 · wk-form4_1770166159.xml · derivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,444 Underlying: Common Stock · 29,444 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation Common Stock. F2 · derivative.exercise_date: 9,814 shares will vest on January 30, 2027; the remaining 19,630 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F2 · derivative.expiration_date: 9,814 shares will vest on January 30, 2027; the remaining 19,630 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
GrantNon-Qualified Stock Options · Derivative | 38,561 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 6 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,561 Underlying: Common Stock · 38,561 shares Expires 2036-01-30 F5 · derivative.exercise_date: 12,853 shares will vest on January 30, 2027; the remaining 25,708 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC |
Hodges Michelle AChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 38,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 5 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,562 Underlying: Common Stock · 38,562 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. F4 · derivative.expiration_date: 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 00:51 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
GrantNon-Qualified Stock Options · Derivative | 36,150 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0002036238-26-000004 · wk-form4_1770166296.xml · derivative · entry 2 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,150 Underlying: Common Stock · 36,150 shares Expires 2036-01-30 F3 · derivative.exercise_date: 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 00:51 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 36,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002036238-26-000004 · wk-form4_1770166296.xml · derivative · entry 1 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,152 Underlying: Common Stock · 36,152 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F2 · derivative.expiration_date: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:07 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,897 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000002 · wk-form4_1770077224.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,796 Underlying: Common Stock · 4,897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 4,897 shares vested on January 29, 2026; the remaining 9,796 shares will vest in equal installments on January 29, 2027 and January 29, 2028. F4 · derivative.expiration_date: 4,897 shares vested on January 29, 2026; the remaining 9,796 shares will vest in equal installments on January 29, 2027 and January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:07 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 2,017 | $27.41 | $55,285.97 |
DisclosureSEC source: 0002045799-26-000002 · wk-form4_1770077224.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,184 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:07 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 4,897 | $0.00 | $0.00 |
DisclosureSEC source: 0002045799-26-000002 · wk-form4_1770077224.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,201 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:07 UTC |
Siegrist Jonathan PhilipEVP of R&D & CTO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0002040321-26-000002 · wk-form4_1770077258.xml · derivative · entry 3 Siegrist Jonathan Philip · CIK 0002040321 · EVP of R&D & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,898 Underlying: Common Stock · 2,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,448 shares vested on January 29, 2026; the remaining 4,898 shares will vest in equal installments on January 29, 2027 and January 29, 2028. F4 · derivative.expiration_date: 2,448 shares vested on January 29, 2026; the remaining 4,898 shares will vest in equal installments on January 29, 2027 and January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:07 UTC |
Siegrist Jonathan PhilipEVP of R&D & CTO
|
Tax withholdingCommon Stock | 1,009 | $27.41 | $27,656.69 |
DisclosureSEC source: 0002040321-26-000002 · wk-form4_1770077258.xml · nonDerivative · entry 2 Siegrist Jonathan Philip · CIK 0002040321 · EVP of R&D & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,419 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:07 UTC |
Siegrist Jonathan PhilipEVP of R&D & CTO
|
GrantCommon Stock | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0002040321-26-000002 · wk-form4_1770077258.xml · nonDerivative · entry 1 Siegrist Jonathan Philip · CIK 0002040321 · EVP of R&D & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,428 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:04 UTC |
Blaser Brian J.President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 21,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001492289-26-000002 · wk-form4_1770077088.xml · derivative · entry 4 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,892 Underlying: Common Stock · 21,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 21,446 shares vested on January 29, 2026; the remaining 42,892 shares will vest in equal installments on January 29, 2027 and January 29, 2028. F4 · derivative.expiration_date: 21,446 shares vested on January 29, 2026; the remaining 42,892 shares will vest in equal installments on January 29, 2027 and January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:04 UTC |
Blaser Brian J.President and CEO
|
Tax withholdingCommon Stock | 7,755 | $27.41 | $212,564.55 |
DisclosureSEC source: 0001492289-26-000002 · wk-form4_1770077088.xml · nonDerivative · entry 2 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,142 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:04 UTC |
Blaser Brian J.President and CEO
|
GrantCommon Stock | 21,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001492289-26-000002 · wk-form4_1770077088.xml · nonDerivative · entry 1 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,897 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,851 Underlying: Common Stock · 8,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 8,425 shares vested on January 29, 2026; 8,425 shares will vest on January 29, 2027; and the remaining 8,426 shares will vest on January 29, 2028. F4 · derivative.expiration_date: 8,425 shares vested on January 29, 2026; 8,425 shares will vest on January 29, 2027; and the remaining 8,426 shares will vest on January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 2,602 | $27.41 | $71,320.82 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,250 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,852 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,673 Underlying: Common Stock · 7,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028. F5 · derivative.expiration_date: 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 3,072 | $27.41 | $84,203.52 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,360 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 7,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,432 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 561 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:05 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,938 | $0.00 | $0.00 |
DisclosureSEC source: 0002036238-26-000002 · wk-form4_1770077153.xml · derivative · entry 3 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,878 Underlying: Common Stock · 2,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,938 shares vested on January 29, 2026; the remaining 5,878 shares will vest in equal installments on January 29, 2027 and January 29, 2028 F4 · derivative.expiration_date: 2,938 shares vested on January 29, 2026; the remaining 5,878 shares will vest in equal installments on January 29, 2027 and January 29, 2028 Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:05 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
Tax withholdingCommon Stock | 1,210 | $27.41 | $33,166.10 |
DisclosureSEC source: 0002036238-26-000002 · wk-form4_1770077153.xml · nonDerivative · entry 2 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 00:05 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
GrantCommon Stock | 2,938 | $0.00 | $0.00 |
DisclosureSEC source: 0002036238-26-000002 · wk-form4_1770077153.xml · nonDerivative · entry 1 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,585 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:37 UTC |
RHOADS ANN DDirector
|
PurchaseCommon Stock | 750 | $28.28 | $21,206.25 |
DisclosureSEC source: 0001250252-25-000004 · wk-form4_1765409834.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,021 Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:33 UTC |
Wilkins Joseph D Jr.Director
|
PurchaseCommon Stock | 370 | $27.96 | $10,343.35 |
DisclosureSEC source: 0001848760-25-000004 · wk-form4_1764624786.xml · nonDerivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,876 Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 21:16 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionNon-Qualified Stock Options · Derivative | 7,021 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001065168-25-000005 · wk-form4_1764105367.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,021 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested in full. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.